| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | Director | Common Stock | 133,364 | 14 Feb 2025 | By Vickers Venture Co-investment LLC | ||
| Aardvark Therapeutics, Inc. | Director | Stock Option (right to buy) | 61,017 | 11 Jun 2025 | Direct | ||
| Aardvark Therapeutics, Inc. | Director | Series C Convertible Preferred Stock | 0 | 14 Feb 2025 | By Vickers Venture Co-investment LLC |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:05 |
| AARD | Aardvark Therapeutics, Inc. | 14 Feb 2025 | 2 | $0 | 4 | Director | 19 Feb 2025, 16:57 |
| AARD | Aardvark Therapeutics, Inc. | 12 Feb 2025 | 0 | $0 | 3 | Director | 12 Feb 2025, 18:55 |